Buskin et al., 2018 - Google Patents
Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosaBuskin et al., 2018
View HTML- Document ID
- 3217283503619681390
- Author
- Buskin A
- Zhu L
- Chichagova V
- Basu B
- Mozaffari-Jovin S
- Dolan D
- Droop A
- Collin J
- Bronstein R
- Mehrotra S
- Farkas M
- Hilgen G
- White K
- Pan K
- Treumann A
- Hallam D
- Bialas K
- Chung G
- Mellough C
- Ding Y
- Krasnogor N
- Przyborski S
- Zwolinski S
- Al-Aama J
- Alharthi S
- Xu Y
- Wheway G
- Szymanska K
- McKibbin M
- Inglehearn C
- Elliott D
- Lindsay S
- Ali R
- Steel D
- Armstrong L
- Sernagor E
- Urlaub H
- Pierce E
- Lührmann R
- Grellscheid S
- Johnson C
- Lako M
- Publication year
- Publication venue
- Nature communications
External Links
Snippet
Mutations in pre-mRNA processing factors (PRPFs) cause autosomal-dominant retinitis pigmentosa (RP), but it is unclear why mutations in ubiquitously expressed genes cause non- syndromic retinal disease. Here, we generate transcriptome profiles from RP11 (PRPF31 …
- 101710039524 PRPF31 0 title abstract description 104
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/606—Transcription factors c-Myc
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Buskin et al. | Disrupted alternative splicing for genes implicated in splicing and ciliogenesis causes PRPF31 retinitis pigmentosa | |
Giannini et al. | TDP-43 mutations link Amyotrophic Lateral Sclerosis with R-loop homeostasis and R loop-mediated DNA damage | |
Bohlen et al. | DENR promotes translation reinitiation via ribosome recycling to drive expression of oncogenes including ATF4 | |
Reynolds et al. | Mutations in DONSON disrupt replication fork stability and cause microcephalic dwarfism | |
Peng et al. | Opposing roles of FANCJ and HLTF protect forks and restrain replication during stress | |
Lenzi et al. | ALS mutant FUS proteins are recruited into stress granules in induced pluripotent stem cell-derived motoneurons | |
Wang et al. | NK4 antagonizes Tbx1/10 to promote cardiac versus pharyngeal muscle fate in the ascidian second heart field | |
Huo et al. | The deubiquitinating enzyme USP 46 regulates AMPA receptor ubiquitination and trafficking | |
Baumgartner et al. | Minor spliceosome inactivation causes microcephaly, owing to cell cycle defects and death of self-amplifying radial glial cells | |
Anantha et al. | Requirement of heterogeneous nuclear ribonucleoprotein C for BRCA gene expression and homologous recombination | |
Futai et al. | Specific trans-synaptic interaction with inhibitory interneuronal neurexin underlies differential ability of neuroligins to induce functional inhibitory synapses | |
Luo et al. | Mir‐23a induces telomere dysfunction and cellular senescence by inhibiting TRF 2 expression | |
Lu et al. | Senescence induced by RECQL4 dysfunction contributes to Rothmund–Thomson syndrome features in mice | |
Chakraborty et al. | DHX9-dependent recruitment of BRCA1 to RNA promotes DNA end resection in homologous recombination | |
Viol et al. | Nek2 kinase displaces distal appendages from the mother centriole prior to mitosis | |
Appel et al. | PHF3 regulates neuronal gene expression through the Pol II CTD reader domain SPOC | |
Zhao et al. | Mouse embryonic stem cells have increased capacity for replication fork restart driven by the specific Filia-Floped protein complex | |
Grange et al. | Pathogenic variants in SLF2 and SMC5 cause segmented chromosomes and mosaic variegated hyperploidy | |
Yang et al. | Genetic and genomic studies of pathogenic EXOSC2 mutations in the newly described disease SHRF implicate the autophagy pathway in disease pathogenesis | |
Pignataro et al. | A missense MT-ND5 mutation in differentiated Parkinson Disease cytoplasmic hybrid induces ROS-dependent DNA Damage Response amplified by DROSHA | |
Cong et al. | PARPi synthetic lethality derives from replication-associated single-stranded DNA gaps | |
Wang et al. | A novel lncRNA Discn fine-tunes replication protein A (RPA) availability to promote genomic stability | |
Han et al. | Global translation during early development depends on the essential transcription factor PRDM10 | |
Xing et al. | Replication stress induces ATR/CHK1-dependent nonrandom segregation of damaged chromosomes | |
Zhu et al. | SUMOylation of HNRNPA2B1 modulates RPA dynamics during unperturbed replication and genotoxic stress responses |